Swiss Electronic Equipment and Components Stock News

Roche Holding (SWX:ROP) reported positive Phase III data for fenebrutinib in relapsing multiple sclerosis, with meaningful reductions in relapse rates and disease burden. The company shared new real world and clinical data in ophthalmology for Vabysmo, Susvimo and investigational IL 6 inhibitor vamikibart, highlighting developments in retinal disease therapies. Roche and Zealand Pharma are moving obesity candidate petrelintide into Phase 3 trials, targeting chronic weight related conditions...

What triggered fresh interest in Siegfried Holding? Siegfried Holding (SWX:SFZN) has drawn attention after raising its 2026 earnings guidance to high single digit net sales growth, while subsidiary DINAMIQS secured Swissmedic approval for cGMP viral vector manufacturing and testing. See our latest analysis for Siegfried Holding. The raised 2026 guidance and DINAMIQS approval come after a mixed share price pattern, with a 1 day share price return of 1.48% and a 90 day share price return...

Why the latest sales update matters for Nestlé shares Nestlé (SWX:NESN) reported first quarter 2026 group sales of CHF 21,317 million compared with CHF 22,601 million a year earlier, yet the stock reacted positively as investors focused on underlying organic growth and pricing. See our latest analysis for Nestlé. That positive reaction around the sales release sits against a mixed share price picture, with a 7.65% 90 day share price return contrasting with a 6.08% decline in the one year...

UBS Group (SWX:UBSG) is in focus after reporting first quarter 2026 earnings, with net profit of US$3.04b and record revenues across core segments, helped by strong trading and Credit Suisse client integration. See our latest analysis for UBS Group. The strong first quarter results have been followed by a sharp rebound in sentiment, with a 6.02% 7 day share price return and 9.77% 30 day share price return, even though the year to date share price return remains down 9.61%. At the same time,...

Zurich Insurance Group (SWX:ZURN) is expanding its technology footprint with a new Global Capability Centre in Hyderabad, India. The centre is aimed at supporting its AI driven transformation and broader digital ambitions across the group. See our latest analysis for Zurich Insurance Group. Despite the new capability centre and recent digital leadership changes in Asia Pacific, Zurich Insurance Group’s share price shows a 1 month share price return decline of 4.73% and a year to date share...

Dividend approval and board refresh put Galderma in focus Galderma Group (SWX:GALD) drew fresh attention after its Annual General Meeting approved a CHF 0.35 per share dividend from capital contribution reserves and confirmed new Board members, including an independent director and two L’Oréal representatives. See our latest analysis for Galderma Group. At a CHF163.8 share price, Galderma’s recent AGM outcomes appear to have supported sentiment, with 1-month and 3-month share price returns of...

ABB (SWX:ABBN) has launched HiPerGuard 34.5kV, a new medium voltage UPS solution targeted at AI focused data centers. The system supports direct grid connection and is designed to deliver significant efficiency gains for large scale data infrastructure. HiPerGuard 34.5kV has received UL 9540 certification, covering integrated battery energy storage systems. The product is being positioned for deployment across key global regions to support rising power and flexibility needs in AI and data...

Q1 trading update puts SGS (SWX:SGSN) in focus SGS (SWX:SGSN) has come onto investors’ radar after its Q1 2026 sales and trading statement call on 23 April, prompting fresh attention on how the testing, inspection and certification group is currently positioned. See our latest analysis for SGS. Following the Q1 2026 trading update, SGS’s share price at CHF84.64 reflects mixed momentum, with a 1 day share price return of 0.76% but a 90 day share price return showing an 8.79% decline, while the...

In late April 2026, SIG announced a two-phase expansion of its Querétaro plant that will double capacity to 3 billion packs annually by 2028, integrate processes like extrusion, and support nearshoring by shifting some production from Europe to Mexico. This move positions Querétaro as SIG’s main North American manufacturing hub, improving regional responsiveness for food and beverage customers while modestly increasing local employment and operational scale in Mexico. We’ll now consider how...

Wondering if Sandoz Group shares still offer value after a strong run, or if most of the opportunity is already priced in? This breakdown will help you assess how the current price compares with fundamentals. The stock last closed at CHF 62.54, with a 7 day return of a 3.1% decline, a 30 day return of 1.3%, and a 1 year return of 76.9% that has attracted significant investor attention. Recent news has focused on Sandoz Group as an established generics and biosimilars business following its...

Wondering if Logitech International at around US$76.74 is priced for opportunity or already reflects the story? This article walks you through what the numbers are actually saying about the stock today. The share price shows mixed recent returns, with 2.0% over the past week and 6.1% over the last month, set against a 3.4% decline year to date but a 25.5% gain over one year and 42.9% over three years, while the five year return stands at a 17.3% decline. Recent headlines around Logitech have...

If you are wondering whether Roche Holding is priced attractively or trading rich right now, the starting point is to look past the ticker and focus on what the current share price implies about value. Roche Holding shares recently closed at CHF318.40, with returns of 2.0% decline over 7 days, 1.2% over 30 days, 2.2% decline year to date, 21.9% over 1 year, 25.2% over 3 years, and 25.5% over 5 years. This gives you a mix of short term softness and longer term gains to interpret. Recent news...

As the pan-European STOXX Europe 600 Index experiences a decline, with defensive sectors like utilities and telecoms showing relative strength amid geopolitical tensions, investors are increasingly on the lookout for overlooked opportunities in the market. In this environment, identifying stocks with strong fundamentals and resilience to economic fluctuations can be crucial for navigating uncertainty.

As European markets navigate a landscape marked by geopolitical tensions and economic uncertainties, major indices such as the STOXX Europe 600 have recently experienced downturns, reflecting broader concerns over energy prices and consumer confidence. In this environment, growth companies with high insider ownership can offer unique insights into potential resilience and alignment of interests between management and shareholders.

Why ABB (SWX:ABBN) Is Back on Investors’ Radar ABB (SWX:ABBN) has attracted fresh attention after a strong run in recent months, prompting investors to reassess how its electrification, motion, and automation businesses align with wider industrial and infrastructure trends. See our latest analysis for ABB. With the share price at CHF78.44, ABB has seen strong recent momentum, including a 24.0% 1 month share price return and an 84.3% 1 year total shareholder return, which puts recent gains...

Nestlé is rolling out an industry first integration between CreativeX and CreatorIQ in its creator led advertising. The company is using AI powered quality controls to bring consistent creative standards to creator campaigns across global markets. This move extends the same level of scrutiny used in traditional media to Nestlé's creator partnerships. For investors tracking SWX:NESN, this shift in creator marketing comes as the shares trade at around CHF79.05 and have seen a 3.4% gain year...

Why the latest trial results matter for Roche Holding (SWX:ROG) Roche Holding (SWX:ROG) has put fresh clinical data in front of investors, with fenebrutinib hitting primary and secondary endpoints in two Phase III trials in relapsing multiple sclerosis. This comes alongside FDA acceptance of a supplemental filing for Gazyva/Gazyvaro in systemic lupus erythematosus. The FENhance 1 and 2 studies reported that fenebrutinib cut annualised relapse rates by 51.1% and 58.5% versus teriflunomide over...

Amrize (SWX:AMRZ) opened Q1 2026 with revenue of US$2.2b and a basic EPS loss of US$0.21, off a net income loss of US$116m for the quarter. Over the last year, the company has seen quarterly revenue move between US$2.1b and US$3.7b, while basic EPS has ranged from a loss of US$0.15 to a high of US$0.99. This gives investors a clear view of how earnings power can swing with the cycle. With trailing 12 month EPS at US$2.09 on net income of US$1.2b and margins easing from 10.6% to 9.7%, the...

Recent share performance and business scale Novartis (SWX:NOVN) has drawn investor attention after a period where the share price shows a 1 day return of 1.2%, a past week return of a 1.9% decline, and a month return of a 5.4% decline. Over the past 3 months, the stock shows a 0.8% decline, while the year to date return stands at 4.5%. The 1 year total return is 24.5%, with 3 year and 5 year total returns of 43.1% and 82.4% respectively. The company reports revenue of $56.6b and net income of...

VAT Group (SWX:VACN) reported first quarter 2026 sales of CHF 221 million and issued new guidance for the second quarter, while reiterating its full year 2026 outlook. See our latest analysis for VAT Group. VAT Group’s latest guidance and first quarter update come after a strong run in the share price, with a 30 day share price return of 23.02% and a 1 year total shareholder return of 103.54%. This suggests momentum has picked up recently even as investors continue to reassess long term...

Readers hoping to buy St. Galler Kantonalbank AG ( VTX:SGKN ) for its dividend will need to make their move shortly, as...

Santhera Pharmaceuticals Holding (SWX:SANN) has opened FY 2025 with first half revenue of CHF 24.0 million and a basic EPS loss of CHF 3.04, with trailing 12 month figures showing revenue of CHF 49.0 million and a basic EPS loss of CHF 5.41, so profitability remains out of reach for now. The company has seen total revenue across the last three reported half year periods move from CHF 14.1 million in H1 2024 to CHF 25.0 million in H2 2024 and CHF 24.0 million in H1 2025, while basic EPS...

Why Sandoz Group is on investors’ radar today Sandoz Group (SWX:SDZ) has drawn fresh attention after its recent share performance and updated fundamentals, prompting investors to reassess how its generic and biosimilar portfolio compares with the current valuation. See our latest analysis for Sandoz Group. At a share price of CHF61.26, Sandoz Group has seen short term softness, with a 1 day share price return of 2.23% decline and a 7 day share price return of 2.82% decline, while its 1 year...

UBS Group Q1 2026 Earnings Snapshot UBS Group (SWX:UBSG) has opened Q1 2026 reporting season following a solid 2025 finish, with Q4 revenue at US$12.8 billion and basic EPS of US$0.39 anchoring the latest set of numbers. The bank reported quarterly revenue rising from US$11.4 billion in Q4 2024 to US$12.8 billion in Q4 2025, while trailing twelve month EPS reached US$2.46 alongside net income of US$7.8 billion. This provides a clear view of how earnings have moved in line with the top line...